Shanghai Junshi Biosciences Co., Ltd. (SHA:688180)

SHA:688180 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 27, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	26,400	35,900	57,208	56,676	64,679	18,716
Market Cap Growth	-16.99%	-37.25%	0.94%	-12.37%	245.58%	15.82%
Enterprise Value	26,233	33,579	55,965	54,189	61,564	17,213
Last Close Price	30.45	41.83	62.60	66.98	81.10	-
PS Ratio	15.36	23.89	39.36	14.08	40.55	24.15
PB Ratio	4.37	4.90	5.85	6.81	11.10	6.28
P/TBV Ratio	4.86	5.44	6.24	7.38	11.42	6.60
EV/Sales Ratio	14.15	22.35	38.50	13.46	38.60	22.21
Debt / Equity Ratio	0.44	0.24	0.14	0.08	0.15	0.29
Asset Turnover	0.16	0.13	0.12	0.42	0.26	0.18
Inventory Turnover	0.95	1.12	0.97	3.04	1.44	0.79
Quick Ratio	1.62	1.91	3.56	2.42	2.77	2.41
Current Ratio	2.00	2.28	4.09	2.92	3.19	3.31
Return on Equity (ROE)	-26.94%	-29.66%	-28.56%	-10.33%	-37.90%	-23.74%
Return on Assets (ROA)	-10.52%	-12.95%	-14.56%	-4.51%	-17.07%	-11.62%
Return on Capital (ROIC)	-12.49%	-15.32%	-17.14%	-5.49%	-20.14%	-13.03%
Earnings Yield	-6.83%	-6.36%	-4.17%	-1.27%	-2.58%	-3.99%
FCF Yield	-8.72%	-7.90%	-3.79%	-2.66%	-3.15%	-10.91%
Buyback Yield / Dilution	-1.33%	-7.16%	-3.20%	-8.28%	-5.58%	-29.35%
Total Shareholder Return	-1.33%	-7.16%	-3.20%	-8.28%	-5.58%	-29.35%

Source: S&P Capital IQ. Standard template. Financial Sources.